Breaking News

Q2 Solutions Collaborates with University of Texas Medical Branch

To develop a novel assay for COVID-19 tests for rapid development of a Coronavirus vaccine.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Q2 Solutions, a clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, is collaborating with the University of Texas Medical Branch (UTMB) to develop a novel assay for COVID-19 (SARS-CoV-2) tests, an essential tool for rapid development of a Coronavirus vaccine. Once a viable assay is developed, Q2 Solutions labs will produce it for use in clinical trials to determine the effectiveness of a COVID-19 vaccine.   An assay is an analysis done t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters